一线治疗药物-话题@MedSci - 梅斯（MedSci）

#一线治疗药物#

12篇内容 | 1045人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2035764, encodeId=81312035e64dd, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物, objectType=article, longId=191689, objectId=a505191689b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a505191689b3, replyNumber=0, likeNumber=86, createdTime=2020-06-08, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a505191689b3, moduleTitle=欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a505191689b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035763, encodeId=08412035e6337, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=Keytruda获得欧盟的批准用于头颈癌的一线治疗药物, objectType=article, longId=183344, objectId=1575183344b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1575183344b0, replyNumber=0, likeNumber=81, createdTime=2020-08-17, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1575183344b0, moduleTitle=Keytruda获得欧盟的批准用于头颈癌的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1575183344b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035762, encodeId=cbfc2035e6289, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, objectType=article, longId=178850, objectId=de591e885009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de591e885009, replyNumber=0, likeNumber=84, createdTime=2019-09-22, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de591e885009, moduleTitle=中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=de591e885009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035761, encodeId=7dbf2035e6152, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=Opdivo/Yervoy联合免疫疗法获批成为晚期肾癌的一线治疗药物, objectType=article, longId=135804, objectId=accc1358048f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=accc1358048f, replyNumber=0, likeNumber=78, createdTime=2018-08-22, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=accc1358048f, moduleTitle=Opdivo/Yervoy联合免疫疗法获批成为晚期肾癌的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=accc1358048f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035760, encodeId=f19b2035e6006, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物, objectType=article, longId=130632, objectId=0a5c130632d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a5c130632d4, replyNumber=0, likeNumber=74, createdTime=2018-07-21, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a5c130632d4, moduleTitle=卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a5c130632d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035759, encodeId=95a42035e5956, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=Ann Intern Med：推荐二甲双胍作为成人2型糖尿病患者的一线治疗药物, objectType=article, longId=72307, objectId=e2c1e230796, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2c1e230796, replyNumber=0, likeNumber=74, createdTime=2017-04-26, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2c1e230796, moduleTitle=Ann Intern Med：推荐二甲双胍作为成人2型糖尿病患者的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e2c1e230796)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035757, encodeId=1b812035e57ca, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=JCO：克唑替尼可以作为ALK阳性非小细胞肺癌一线治疗药物, objectType=article, longId=65871, objectId=541e658e142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=541e658e142, replyNumber=0, likeNumber=77, createdTime=2016-09-05, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=541e658e142, moduleTitle=JCO：克唑替尼可以作为ALK阳性非小细胞肺癌一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=541e658e142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035758, encodeId=3f632035e5850, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=慢性乙肝一线治疗药物替诺福韦酯等大降价, objectType=article, longId=68820, objectId=65866882079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65866882079, replyNumber=0, likeNumber=72, createdTime=2017-04-16, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65866882079, moduleTitle=慢性乙肝一线治疗药物替诺福韦酯等大降价, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=65866882079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035756, encodeId=28bb2035e56d8, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=Ann Intern Med：泼尼松龙——急性痛风的一线治疗药物, objectType=article, longId=63777, objectId=213463e778f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=213463e778f, replyNumber=0, likeNumber=100, createdTime=2016-07-14, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=213463e778f, moduleTitle=Ann Intern Med：泼尼松龙——急性痛风的一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=213463e778f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035755, encodeId=39812035e551d, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=ESC 2015：心包疾病指南亮点，秋水仙碱作为一线治疗药物, objectType=article, longId=55529, objectId=809655529d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=809655529d2, replyNumber=0, likeNumber=90, createdTime=2015-11-22, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=809655529d2, moduleTitle=ESC 2015：心包疾病指南亮点，秋水仙碱作为一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=809655529d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035754, encodeId=88f12035e54e3, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, objectType=article, longId=49414, objectId=79a64941446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79a64941446, replyNumber=0, likeNumber=80, createdTime=2015-11-02, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79a64941446, moduleTitle=SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79a64941446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035753, encodeId=b1d82035e53ae, content=<a href='/topic/show?id=474519425c8' target=_blank style='color:#2F92EE;'>#一线治疗药物#</a>, objectTitle=Circulation：曲罗尼尔有望成为肺动脉高压一线治疗药物, objectType=article, longId=14717, objectId=4e1514e1726, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1514e1726, replyNumber=0, likeNumber=90, createdTime=2013-06-12, rootId=0, userName=闆锋旦, userId=8409354, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1514e1726, moduleTitle=Circulation：曲罗尼尔有望成为肺动脉高压一线治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e1514e1726)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

一线治疗药物

2020-05-29

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物

2020-06-08

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

Keytruda获得欧盟的批准用于头颈癌的一线治疗药物

2020-08-17

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

中国监管机构批准阿斯利康的Tagrisso作为EGFR突变型NSCLC的一线治疗药物

2019-09-22

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

Opdivo/Yervoy联合免疫疗法获批成为晚期肾癌的一线治疗药物

2018-08-22

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

卡博替尼有望成为放射性碘拮抗的甲状腺癌一线治疗药物

2018-07-21

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

Ann Intern Med：推荐二甲双胍作为成人2型糖尿病患者的一线治疗药物

2017-04-26

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

JCO：克唑替尼可以作为ALK阳性非小细胞肺癌一线治疗药物

2016-09-05

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

慢性乙肝一线治疗药物替诺福韦酯等大降价

2017-04-16

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

Ann Intern Med：泼尼松龙——急性痛风的一线治疗药物

2016-07-14

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

ESC 2015：心包疾病指南亮点，秋水仙碱作为一线治疗药物

2015-11-22

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

SC-ICC2015：孙宁玲--β受体阻滞剂可作为高血压一线治疗药物吗？

2015-11-02

闆锋旦 (审核中...)

前往app查看评论内容

#一线治疗药物#

Circulation：曲罗尼尔有望成为肺动脉高压一线治疗药物

2013-06-12

科室
- - 订阅+
  - 更多科室
工具
服务